As of November 12, 2026, Kanna (Sceletium tortuosum) is legal to sell at retail in Arizona. Not scheduled or named in Arizona law; no kanna or Sceletium provision. Controlling source: A.R.S. Sec. 13-3401(6)(a) (Definitions: dangerous drug (hallucinogenic substances)).
Verified November 12, 2026 (hash check) · confidence: confirmedIs Kanna Legal? Every state and federal law
Arizona lists hallucinogenic dangerous drugs in A.R.S. 13-3401(6)(a), a closed list (including mescaline, psilocybin, psilocyn, bufotenine); kanna, Sceletium tortuosum and mesembrine are absent. The pharmacy board Schedule I adopts 21 CFR 1308.11 and 13-3401 by reference (A.R.S. 36-2512), and neither lists them. The kratom consumer protection act (A.R.S. 36-795 to 36-795.03) does not mention kanna. No Arizona statute naming kanna or Sceletium was found. A.R.S. 13-3401(6)(c)(xliii), under a chapeau for substances with a stimulant effect, covers methoxyphenethylamine mimetic substances derived from 2,5-dimethoxy-phenethylamine by substitution at the ring, the nitrogen or the ethylamine carbons. Mesembrine carries 3,4-dimethoxy rather than 2,5-dimethoxy ring substitution and its ethylamine carbons sit inside a fused ring system, so reaching it would require reading the clause well beyond its 2C-series target; the row stays legal, and the clause is noted for completeness. Not federally controlled; FDA food and supplement law applies (see the federal page).
6. “Dangerous drug” means the following by whatever official, common, usual, chemical or trade name designated: ... (a) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted ... (xxi) Mescaline.
Among Arizona's 5 neighbors, California, Colorado, New Mexico, Nevada and Utah are legal, the same posture as Arizona.
Open the interactive map · Every compound in Arizona · Where Kanna is banned · Embed this map
Not federally scheduled. Not federally controlled; sold under FDA dietary supplement and food law Federal detail
6 instruments on file for this compound’s framework in Arizona; 3 of 3 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
65601d2904c0255e(xxx) N-methyltryptamine mimetic substances that are any substances derived from N-methyltryptamine by any substitution at the nitrogen, any substitution at the indole ring, any substitution at the alpha carbon, any substitution at the beta carbon or any combination of the above. N-methyltryptamine mimetic substances do not include melatonin (5-methoxy n-acetyltryptamine). Substances in the N-methyltryptamine generic definition include AcO-DMT, Baeocystine, Bromo-DALT, DiPT, DMT, DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO-MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT and Norbufotenin.
7d8967c94071fba26. “Dangerous drug” means the following by whatever official, common, usual, chemical or trade name designated: (a) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Alpha-ethyltryptamine. (ii) Alpha-methyltryptamine. (iii) (2-aminopropyl) benzofuran (APB). (iv) (2-aminopropyl)-2, 3-dihydrobenzofuran (APDB). (v) Aminorex. (vi) 4-bromo-2, 5-dimethoxyphenethylamine. (vii) 4-bromo-2, 5-dimethoxyamphetamine. (viii) Bufotenine. (ix) [3-(3-carbamoylphenyl)phenyl]N-cyclohexyl carbamate (URB-597). (x) Diethyltryptamine. (xi) 2, 5-dimethoxyamphetamine. (xii) Dimethyltryptamine. (xiii) (2-ethylaminopropyl)-benzofuran (EAPB). (xiv) 5-methoxy-alpha-methyltryptamine. (xv) 5-methoxy-3, 4-methylenedioxyamphetamine. (xvi) 4-methyl-2, 5-dimethoxyamphetamine. (xvii) (2-methylaminopropyl)-benzofuran (MAPB). (xviii) Ibogaine. (xix) Lysergic acid amide. (xx) Lysergic acid diethylamide. (xxi) Mescaline. (xxii) 4-methoxyamphetamine. (xxiii) Methoxymethylenedioxyamphetamine (MMDA). (xxiv) Methylenedioxyamphetamine (MDA). (xxv) 3, 4-methylenedioxymethamphetamine. (xxvi) 3, 4-methylenedioxy-N-ethylamphetamine. (xxvii) N-ethyl-3-piperidyl benzilate (JB-318). (xxviii) N-hydroxy-3, 4-methylenedioxyamphetamine. (xxix) N-methyl-3-piperidyl benzilate (JB-336). (xxx) N-methyltryptamine mimetic substances that are any substances derived from N-methyltryptamine by any substitution at the nitrogen, any substitution at the indole ring, any substitution at the alpha carbon, any substitution at the beta carbon or any combination of the above. N-methyltryptamine mimetic substances do not include melatonin (5-methoxy n-acetyltryptamine). Substances in the N-methyltryptamine generic definition include AcO-DMT, Baeocystine, Bromo-DALT, DiPT, DMT, DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO-MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT and Norbufotenin. (xxxi) N-(1-phenylcyclohexyl) ethylamine (PCE). (xxxii) Nabilone. (xxxiii) 1-(1-phenylcyclohexyl) pyrrolidine (PHP). (xxxiv) 1-(1-(2-thienyl)-cyclohexyl) piperidine (TCP). (xxxv) 1-(1-(2-thienyl)-cyclohexyl) pyrrolidine. (xxxvi) Para-methoxyamphetamine (PMA). (xxxvii) Psilacetin. (xxxviii) Psilocybin. (xxxix) Psilocyn. (xl) Synhexyl. (xli) Trifluoromethylphenylpiperazine (TFMPP). (xlii) Trimethoxyamphetamine (TMA). (xliii) 1-pentyl-3-(naphthoyl)indole (JWH-018 and isomers). (xliv) 1-butyl-3-(naphthoyl)indole (JWH-073 and isomers). (xlv) 1-hexyl-3-(naphthoyl)indole (JWH-019 and isomers). (xlvi) 1-pentyl-3-(4-chloro naphthoyl)indole (JWH-398 and isomers). (xlvii) 1-(2-(4-(morpholinyl)ethyl))-3-(naphthoyl)indole (JWH-200 and isomers). (xlviii) 1-pentyl-3-(methoxyphenylacetyl)indole (JWH-250 and isomers). (xlix) (2-methyl-1-propyl-1H-indol-3-YL)-1-naphthalenyl-methanone (JWH-015 and isomers). (l) (6AR, 10AR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan2-Y)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) (HU-210). (li) 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol (CP 47,497 and isomers). (lii) 5-(1,1-dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol (cannabicyclohexanol, CP-47,497 C8 homologue and isomers). (liii) Xylazine.
b96c6eb61c72350e(d) Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: (i) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, unless specifically excepted. (ii) Alprazolam. (iii) Bromazepam. (iv) Camazepam. (v) Carisoprodol. (vi) Chloral betaine. (vii) Chloral hydrate. (viii) Chlordiazepoxide. (ix) Chlorhexadol. (x) Clobazam. (xi) Clonazepam. (xii) Clorazepate. (xiii) Clotiazepam. (xiv) Cloxazolam. (xv) Delorazepam. (xvi) Diazepam. (xvii) Dichloralphenazone. (xviii) Estazolam. (xix) Ethchlorvynol. (xx) Ethinamate. (xxi) Ethyl loflazepate. (xxii) Etizolam. (xxiii) Fenfluramine. (xxiv) Fludiazepam. (xxv) Flunitrazepam. (xxvi) Flurazepam. (xxvii) Gamma hydroxy butyrate. (xxviii) Glutethimide. (xxix) Halazepam. (xxx) Haloxazolam. (xxxi) Hydroxyphencyclidine (HO-PCP). (xxxii) Ketamine. (xxxiii) Ketazolam. (xxxiv) Loprazolam. (xxxv) Lorazepam. (xxxvi) Lormetazepam. (xxxvii) Lysergic acid. (xxxviii) Mebutamate. (xxxix) Mecloqualone. (xl) Medazepam. (xli) Meprobamate. (xlii) Methaqualone. (xliii) Methohexital. (xliv) 2-(methoxyphenyl)-2-(ethylamino)cyclohexanone (Methoxetamine). (xlv) 2-(methoxyphenyl)-2-(methylamino)cyclohexanone (Methoxyketamine). (xlvi) Methoxyphencyclidine(MeO-PCP). (xlvii) Methyprylon. (xlviii) Midazolam. (xlix) Nimetazepam. (l) Nitrazepam. (li) Nordiazepam. (lii) Oxazepam. (liii) Oxazolam. (liv) Paraldehyde. (lv) Petrichloral. (lvi) Phencyclidine (PCP). (lvii) Phencyclidine mimetic substances that are any substances derived from phenylcyclohexylpiperidine by any substitution at the phenyl ring, any substitution at the piperidine ring, any substitution at the cyclohexyl ring, any replacement of the phenyl ring or any combination of the above. Substances in the phenylcyclohexylpiperidine generic definition include Amino-PCP, BCP, Bromo-PCP, BTCP, Chloro-PCP, Fluoro-PCP, HO-PCP, MeO-PCP, Methyl-PCP, Nitro-PCP, Oxo-PCP, PCE, PCM, PCPY, TCP and TCPY. (lviii) Pinazepam. (lix) Prazepam. (lx) Scopolamine. (lxi) Sulfondiethylmethane. (lxii) Sulfonethylmethane. (lxiii) Sulfonmethane. (lxiv) Quazepam. (lxv) Temazepam. (lxvi) Tetrazepam. (lxvii) Tiletamine. (lxviii) Triazolam. (lxix) Zaleplon. (lxx) Zolazepam. (lxxi) Zolpidem. (lxxii) Zopiclone.
c3eb39cb2e5efcdaA. A person who knowingly possesses, sells, transfers or offers to sell or transfer peyote is guilty of a class 6 felony. B. In a prosecution for violation of this section, it is a defense that the peyote is being used or is intended for use: 1. In connection with the bona fide practice of a religious belief, and 2. As an integral part of a religious exercise, and 3. In a manner not dangerous to public health, safety or morals.
01565bb04264b024A. A person shall not knowingly: 1. Breathe, inhale or drink a vapor-releasing substance containing a toxic substance. 2. Sell, transfer or offer to sell or transfer a vapor-releasing substance containing a toxic substance to a person under eighteen years of age. 3. Sell, transfer or offer to sell or transfer a vapor-releasing substance containing a toxic substance if such person is not, at the time of sale, transfer or offer, employed by or engaged in operating a licensed commercial establishment at a fixed location regularly offering such substance for sale and such sale, transfer or offer is made in the course of employment or operation. B. A person making a sale or transfer of a vapor-releasing glue containing a toxic substance shall require identification of the purchaser and shall record: 1. The name of the glue. 2. The date and hour of delivery. 3. The intended use of the glue. 4. The signature and address of the purchaser. 5. The signature of the seller or deliverer. Such record shall be kept for three years and be available to board inspectors and peace officers. C. The operator of a commercial establishment shall keep all vapor-releasing glue containing a toxic substance in a place that is unavailable to customers without the assistance of the operator or an employee of the establishment. D. The operator of a commercial establishment selling vapor-releasing paints and varnishes containing a toxic substance dispensed by the use of any aerosol spray device shall conspicuously display an easily legible sign of not less than eleven by fourteen inches which states: “Warning: inhalation of vapors can be dangerous”. E. This section is not applicable to the transfer of a vapor-releasing substance containing a toxic substance from a parent or guardian to his child or ward, or the sale or transfer made for manufacturing or industrial purposes. F. Subsection A, paragraphs 2 and 3 and subsections B and C do not apply to substances certified by the department of health services as containing an additive that inhibits inhalation or induces sneezing. G. A person who violates any provision of this section is guilty of a class 5 felony, but the court, having regard to the nature and circumstances of the offense, may enter judgment of conviction for a class 1 misdemeanor and make disposition accordingly or may place the defendant on probation in accordance with chapter 9 of this title and refrain from designating the offense as a felony or misdemeanor until the probation is terminated. The offense shall be treated as a felony for all purposes until such time as the court enters an order designating the offense a misdemeanor. H. For the purposes of subsections A and E, “vapor-releasing substance containing a toxic substance” means paint or varnish dispensed by the use of aerosol spray, or any glue, that releases vapors or fumes containing acetone, volatile acetates, benzene, butyl alcohol, ethyl alcohol, ethylene dichloride, isopropyl alcohol, methyl alcohol, methyl ethyl ketone, pentachlorophenol, petroleum ether, toluene, volatile ketones, isophorone, chloroform, methylene chloride, mesityl oxide, xylene, cumene, ethylbenzene, trichloroethylene, mibk, miak, mek or diacetone alcohol or isobutyl nitrite.
4702a88018b06ab613-3403.01 . Nitrous oxide containers; sale to minors; classification A. A person shall not knowingly sell, give or deliver to a person under eighteen years of age any container exclusively containing nitrous oxide, unless the person under eighteen years of age is delivering or accepting delivery in the person’s capacity as an employee. B. A person who violates this section is guilty of a class 5 felony unless the court does either of the following: 1. Enters a judgment of conviction for a class 1 misdemeanor and makes disposition accordingly. 2. Places the person on probation in accordance with chapter 9 of this title and refrains from designating the offense as a felony or misdemeanor until the probation is terminated. The offense shall be treated as a felony for all purposes until such time as the court may actually enter an order designating the offense as a misdemeanor.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap